Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Camidge, D Ross ; Kim, Hye Ryun ; Ahn, Myung-Ju ; Yang, James C H ; Han, Ji-Youn ; Hochmair, Maximilian J ; Lee, Ki Hyeong ; Delmonte, Angelo ; García Campelo, Maria Rosario ; Kim, Dong-Wan ; Griesinger, Frank ; Felip, Enriqueta ; Califano, Raffaele ; Spira, Alexander ; Gettinger, Scott N ; Tiseo, Marcello ; Lin, Huamao M ; Gupta, Neeraj ; Hanley, Michael J ; Ni, Quanhong ; Zhang, Pingkuan ; Popat, Sanjay

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3592-3603 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível